COVID 19 patients develop thik mucus in the lungs and in cavities which lodges virus and protect virus from actions of antiviral medicines, by hindering the molecule form reaching to the point of viral particles.
Also the stress is put on the lungs to expel the thick mucus by coughing action is reduced thereby reducing the damage to the lungs.
Bromohexine Hydrochloride |
Bromohexine Hydrochloride liquify thick mucus and it is expelled easily by patients, with just coughing action, which intern protect lungs from adverse effects of virus on lungs.
Also Other combination drugs Bromohexine Ambroxol as well as Guefenesine are mucolytic drug's these help in mucolytic and hydrolytic action on viral particles as well.
Mode of action of Bromohexine : Bromohexine increase lysosomal secretion in lungs brings about hydrolysis of mucopolysaccharide, which intern also may be acting on viral particle as well.
While opoidal drugs which are used in Cough Syrup must be avoided it is found that opoidal drug have increased the replication and growth of SARS-COV-2 virus which in turn is life-threatening. Such Cough Syrups medicines must be Avoided.
And early treatment with Bromohexin containg cough syrup or Tablet helps to recover without admission in to ICU, and mechanical ventilation.
REFERENCE
1) BROMOHEXIN Early treatment prevents instances of ICU admissions and Mechanical Ventilation, Intubation.
2) Mode of action of Bromhexine Hydrochloride: https://pubchem.ncbi.nlm.nih.gov/compound/Bromhexine-hydrochloride
What must be avoided, the opoidal drugs increase mortality in COVID 19 patients.
Authored by
Bhimrao Waghmare
B Pharma.
No comments:
Post a Comment